This Global Plan builds on the previous edition, which laid out priority actions for 2018-2022, informed by global commitments member states endorsed at the 2018 United Nations High-Level Meeting (UNHLM) on TB. The resource needs estimates from this... Global Plan include resources needed for implementing TB care and prevention and R&D into new tools. This Global Plan has already informed the Global Fund Investment Case and the 2022 G20 deliberations on TB. It will serve as a key document for inspiring and aligning global advocacy efforts, such as for the upcoming UNHLM on TB in 2023.
more
Evaluation report November 2014
On the road to ending TB
Highlights from the 30 highest TB burden countries
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with ...ss="attribute-to-highlight medbox">HIV to reduce HIV-related morbidity and mortality. Further, co-trimoxazole is an off-patent drug and widely available in resource-limited settings.
more
Meeting report, 25-26 September 2017 Copenhagen, Denmark
Copenhagen, Denmark, 24–25 August 2017
Participant Manual September 2009
PLOS ONE | www.plosone.org
September 2014 | Volume 9 | Issue 9 | e103657